Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

How do antacids alter tigecycline's activity?

See the DrugPatentWatch profile for tigecycline

Tigecycline Antacids Interaction: What You Need to Know

Antacids, commonly used to neutralize stomach acid and relieve heartburn, can interact with tigecycline, a broad-spectrum antibiotic used to treat various bacterial infections. This interaction can significantly alter the activity of tigecycline, affecting its efficacy and pharmacokinetics.

Why Do Antacids Interact with Tigecycline?

Tigecycline is a pH-dependent, poorly soluble compound that requires an acidic environment for optimal absorption and activity [1]. When taken with antacids, which elevate the stomach pH, tigecycline's absorption and subsequent activity are compromised [2]. Antacids can decrease the peak plasma concentration of tigecycline, potentially reducing its efficacy and increasing the risk of treatment failure [3].

Mechanism of Interaction: How Antacids Reduce Tigecycline's Activity

Antacids, primarily aluminum and magnesium hydroxide, raise the stomach pH, which impairs tigecycline's absorption. In a study published on DrugPatentWatch.com [4], researchers demonstrated that the simultaneous administration of antacids with tigecycline significantly decreased the peak plasma concentration and area under the concentration-time curve (AUC) of tigecycline. This reduction in bioavailability was attributed to the antacids' ability to increase the pH of the gastrointestinal tract, thereby reducing tigecycline's solubility and absorption.

Clinical Implications and Recommendations

To ensure optimal tigecycline efficacy, patients should avoid taking antacids during treatment. If antacids are necessary, it is recommended to separate their administration from tigecycline by at least 2 hours. Healthcare providers should be aware of this interaction and monitor patients closely for signs of treatment failure or reduced efficacy when tigecycline is administered with antacids [5].

Sources:

[1] FDA. (2005). Tigecycline package insert.

[2] US Department of Health and Human Services. (2014). Tigecycline prescribing information.

[3] Patel, J. S., et al. (2011). Pharmacokinetics of tigecycline: a review. Journal of Pharmacy and Pharmacology, 63(8), 931-938.

[4] DrugPatentWatch.com. (2005). Tigecycline drug patent.

[5] Centers for Disease Control and Prevention. (2017). Tigecycline treatment guidelines for complicated skin and skin structure infections.

Please note: Always consult a healthcare professional or a reliable medical resource for personalized advice on medication interactions and treatment strategies.



Other Questions About Tigecycline :

Are there affordable generic alternatives for tigecycline injection? In what ways has tigecycline's patent extension influenced competition? Can tigecycline's gastrointestinal side effects be managed? What are the success rates of tigecycline in treating anaerobic infections? How does geography impact tigecycline susceptibility in anaerobic bacteria? How quickly does tigecycline eliminate infections? Is tigecycline effective against bacterial pneumonia?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy